| [1] |
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3):304-377.
|
| [2] |
Donnelly JP, Safford MM, Shapiro NI, et al. Application of the third international consensus definitions for sepsis (sepsis-3) classification: retrospective population-based cohort study[J]. Lancet Infect Dis, 2017, 17(6):661-670.
|
| [3] |
Raith EP, Udy AA, Bailey M, et al. Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE). Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit[J]. JAMA, 2017, 317(3):290-300.
|
| [4] |
Shankar-Hari M, Phillips GS, Levy ML et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8):775-787.
|
| [5] |
Verdonk F, Blet A, Mebazaa A. The new sepsis definition: limitations and contribution to research and diagnosis of sepsis[J]. Curr Opin Anaesthesiol, 2017, 30(2):200-204.
|
| [6] |
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
|
| [7] |
Zhou J, Tian H, Du X, et al. China Critical Care Clinical Trials Group (CCCCTG). Population-based epidemiology of sepsis in a sub district of Beijing[J]. Crit Care Med, 2017, 45(7):1168-1176.
|
| [8] |
PRISM Investigators, Rowan KM, Angus DC, et al. Early, goal-directed therapy for septic shock-apatient-level meta-analysis[J]. N Engl J Med, 2017, 376(23):2223-2234.
|
| [9] |
Seymour CW, Gesten F, Prescott HC, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis[J]. N Engl J Med, 2017, 376(23):2235-2244.
|
| [10] |
Chertoff J, Chisum M, Simmons L, et al. Prognostic utility of plasma lactate measured between 24 and 48 h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis, and septic shock[J]. J Intensive Care, 2016, 4:13.
|
| [11] |
Leisman D, Wie B, Doerfler M, et al. Association of fluid resuscitation initiation within 30 minutes of severe sepsis and septic shock recognition with reduced mortality and length of stay[J]. Ann Emerg Med, 2016, 68(3):298-311.
|
| [12] |
Brotfain E, Koyfman L, Toledano R, et al. Positive fluid balance as a major predictor of clinical outcome of patients with sepsis/septic shock after ICU discharge[J]. Am J Emerg Med, 2016, 34(11):2122-2126.
|
| [13] |
Sakr Y, RubattoBirri PN, Kotfis K, et al. Intensive Care Over Nations Investigators. Higher fluid balance increases the risk of death from sepsis: results from a large international audit[J]. Crit Care Med, 2017, 45(3):386-394.
|
| [14] |
Besen BA, Taniguchi LU. Negative Fluid Balance in Sepsis: When and How?[J]. Shock, 2017, 47(1S Suppl 1):35-40.
|
| [15] |
Byrne L, Van Haren F. Fluid resuscitation in human sepsis: Time to rewrite history?[J]. Ann Intensive Care, 2017, 7(1):4.
|
| [16] |
Avni T, Lador A, Lev S, et al. Vasopressors for the treatment of septic shock: systematic review and meta-analysis[J]. PLoS One, 2015, 10(8):e0129305.
|
| [17] |
Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial[J]. JAMA, 2016, 316(5):509-518
|
| [18] |
Zhou F, Mao Z, Zeng X, et al. Vasopressors in septic shock: a systematic review and network meta-analysis[J]. Ther Clin Risk Manag, 2015, 11:1047-1059.
|
| [19] |
Alberto L, Marshall AP, Walker R, et al. Screening for sepsis in general hospitalized patients: a systematic review[J]. J Hosp Infect, 2017, 96(4):305-315.
|
| [20] |
Sager R, Kutz A, Mueller B, et al. Procalcitonin- guided diagnosis and antibiotic stewardship revisited[J]. BMC Med, 2017, 15(1):15.
|
| [21] |
Ohji G, Doi A, Yamamoto S, Iwata K．Is de-escalation of antimicrobials effective? A systematic review and meta-analysis[J]. Int J Infect Dis, 2016, 49:71-79.
|
| [22] |
Schuetz P, Birkhahn R, Sherwin R, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenterprocalcitonin monitoring sepsis (MOSES) study[J]. Crit Care Med, 2017, 45(5):781-789.
|
| [23] |
Lagunes L, Encina B, Ramirez-Estrada S. Current understanding in source control management in septic shock patients: a review[J]. Ann Transl Med, 2016, 4(17):330.
|
| [24] |
Gibbison B, López-López JA, Higgins JPT, et al. Corticosteroids in septic shock: a systematic review and network meta-analysis[J]. Critical Care, 2017, 21(1):78.
|
| [25] |
Ryg？rd SL, Holst LB, Wetterslev J, et al. TRISS trial group; Scandinavian Critical Care Trials Group. Higher vs. lower haemoglobin threshold for transfusion in septic shock: subgroup analyses of the TRISS trial[J]. Acta Anaesthesiol Scand, 2017, 61(2):166-175.
|
| [26] |
Kaufman RM, Djulbegovic B, Gernsheimer T, et al. AABB. Platelet transfusion: a clinical practice guideline from the AABB[J]. Ann Intern Med, 2015, 162(3):205-213.
|
| [27] |
Fan Y, Jiang M, Gong D, et al. Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials[J]. Sci Rep, 2016, 6:25984.
|
| [28] |
Murray MJ, DeBlock H, Erstad B, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient[J]. Crit Care Med, 2016, 44(11):2079-2103.
|
| [29] |
Kalfon P, Le Manach Y, Ichai C, et al. CGAO-REA Study Group. Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients[J]. Crit Care, 2015, 19:153.
|
| [30] |
Qaseem A, Chou R, Humphrey LL, et al. Clinical Guidelines Committee of the American College of Physicians. Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians[J]. Am J Med Qual, 2014, 29(2):95-98.
|
| [31] |
Ramamurthy M．Trial of the route of early nutritional support in critically ill adults[J]. N Engl J Med, 2015, 372(5):488.
|
| [32] |
Elke G, van Zanten AR, Lemieux M, et al. Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials[J]. Crit Care, 2016, 20(1):117.
|
| [33] |
Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN randomized clinical trial[J]. JAMA, 2016, 315(20):2190-2199.
|
| [34] |
Gaudry S, Hajage D, Schortgen F, et al. AKIKI Study Group. Initiation strategies for renal-replacement therapy in the intensive care unit[J]. N Engl J Med, 2016, 375(2):122-33.
|
| [35] |
Nash DM, Przech S, Wald R, et al. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit[J]. J Crit Care, 2017, 41:138-144.
|
| [36] |
Beitland S, Sandven I, Kj？rvik LK, et al. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis[J]. Intensive Care Med, 2015, 41(7):1209-1219.
|
| [37] |
Pavon JM, Adam SS, Razouki ZA, et al. Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review[J]. J Arthroplasty, 2016, 31(2):524-532.
|
| [38] |
Alshamsi F, Belley-Cote E, Cook D, et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials[J]. Crit Care, 2016, 20(1):120.
|
| [39] |
Sasabuchi Y, Matsui H, Lefor AK, et al. Risks and benefits of stress ulcer prophylaxis for patients with severe sepsis[J]. Crit Care Med, 2016, 44(7):e464-e469.
|
| [40] |
Kon AA, Davidson JE, Morrison W, et al. American College of Critical Care Medicine; American Thoracic Society. Shared Decision Making in ICUs：An American College of Critical Care Medicine and American Thoracic Society Policy Statement[J]. Crit Care Med, 2016, 44(1):188-201.
|